Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Bleeding and Blood Disorders in Clients of Voluntary Medical Male Circumcision for HIV Prevention - Eastern and Southern Africa, 2015-2016.

Hinkle LE, Toledo C, Grund JM, Byams VR, Bock N, Ridzon R, Cooney C, Njeuhmeli E, Thomas AG, Odhiambo J, Odoyo-June E, Talam N, Matchere F, Msungama W, Nyirenda R, Odek J, Come J, Canda M, Wei S, Bere A, Bonnecwe C, Choge IA, Martin E, Loykissoonlal D, Lija GJI, Mlanga E, Simbeye D, Alamo S, Kabuye G, Lubwama J, Wamai N, Chituwo O, Sinyangwe G, Zulu JE, Ajayi CA, Balachandra S, Mandisarisa J, Xaba S, Davis SM.

MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):337-339. doi: 10.15585/mmwr.mm6711a6.

2.

Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.

Alexandre KB, Gray ES, Lambson BE, Moore PL, Choge IA, Mlisana K, Karim SS, McMahon J, O'Keefe B, Chikwamba R, Morris L.

Virology. 2010 Jun 20;402(1):187-96. doi: 10.1016/j.virol.2010.03.021. Epub 2010 Apr 13.

3.

The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection.

Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L; CAPRISA 002 Study Team.

J Virol. 2008 Feb;82(4):1860-9. Epub 2007 Dec 5.

4.

Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies.

Rademeyer C, Moore PL, Taylor N, Martin DP, Choge IA, Gray ES, Sheppard HW, Gray C, Morris L, Williamson C; HIVNET 028 study team.

Virology. 2007 Nov 10;368(1):172-81. Epub 2007 Jul 16.

5.

Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.

Gray ES, Moore PL, Choge IA, Decker JM, Bibollet-Ruche F, Li H, Leseka N, Treurnicht F, Mlisana K, Shaw GM, Karim SS, Williamson C, Morris L; CAPRISA 002 Study Team.

J Virol. 2007 Jun;81(12):6187-96. Epub 2007 Apr 4.

6.

Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children.

Walker PR, Ketunuti M, Choge IA, Meyers T, Gray G, Holmes EC, Morris L.

AIDS Res Hum Retroviruses. 2007 Feb;23(2):204-15.

PMID:
17331028
7.

Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals.

Bessong PO, Mphahlele J, Choge IA, Obi LC, Morris L, Hammarskjold ML, Rekosh DM.

AIDS Res Hum Retroviruses. 2006 Dec;22(12):1306-12.

PMID:
17209775
8.

High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.

Walker PR, Cilliers T, Choge IA, Taylor N, Cohen SS, Morris L.

J Med Virol. 2006 Oct;78(10):1262-8.

PMID:
16927278

Supplemental Content

Loading ...
Support Center